atorvastatin tad 40 mg apvalkotās tabletes
tad pharma gmbh, germany - atorvastatīns - apvalkotā tablete - 40 mg
atorvastatin teva 40 mg apvalkotās tabletes
teva pharma b.v., netherlands - atorvastatīns - apvalkotā tablete - 40 mg
atorvastatin teva 10 mg apvalkotās tabletes
teva pharma b.v., netherlands - atorvastatīns - apvalkotā tablete - 10 mg
atorvastatin teva 20 mg apvalkotās tabletes
teva pharma b.v., netherlands - atorvastatīns - apvalkotā tablete - 20 mg
caduet 10 mg/10 mg apvalkotās tabletes
upjohn eesv, netherlands - amlodipinum, atorvastatinum - apvalkotā tablete - 10 mg/10 mg
suvarol 10 mg/20 mg apvalkotās tabletes
zaklady farmaceutyczne polpharma s.a., poland - amlodipinum, atorvastatinum - apvalkotā tablete - 10 mg/20 mg
suvarol 10 mg/10 mg apvalkotās tabletes
zaklady farmaceutyczne polpharma s.a., poland - amlodipinum, atorvastatinum - apvalkotā tablete - 10 mg/10 mg
suvarol 5 mg/10 mg apvalkotās tabletes
zaklady farmaceutyczne polpharma s.a., poland - amlodipinum, atorvastatinum - apvalkotā tablete - 5 mg/10 mg
suvarol 5 mg/20 mg apvalkotās tabletes
zaklady farmaceutyczne polpharma s.a., poland - amlodipinum, atorvastatinum - apvalkotā tablete - 5 mg/20 mg
delstrigo
merck sharp & dohme b.v. - doravirine, lamivudīnu, tenofovir disoproxil fumarate - hiv infekcijas - antivirals for treatment of hiv infections, combinations - delstrigo ir indicēts, lai ārstētu pieaugušos ar hiv inficēti 1 bez pagātnes vai tagadnes pierādījumus par pretestību nnrti klases, lamivudīnu, vai tenofovir. delstrigo is also indicated for the treatment of adolescents aged 12 years and older weighing at least 35 kg who are infected with hiv-1 without past or present evidence of resistance to the nnrti class, lamivudine, or tenofovir and who have experienced toxicities which preclude the use of other regimens that do not contain tenofovir disoproxil.